|Bid||0.364 x 13800|
|Ask||0.368 x 600|
|Day's Range||0.360 - 0.380|
|52 Week Range||0.330 - 1.750|
|PE Ratio (TTM)||-6.50|
|Earnings Date||Aug 8, 2017 - Aug 14, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||3.25|
HOUSTON, July 17, 2017-- Bio-Path Holdings, Inc.,, a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid ...
DALLAS, TX / ACCESSWIRE / June 29, 2017 / Stonegate Capital Partners updates research coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH). COMPANY DESCRIPTION Bio-Path Holdings, Inc. (Bio-Path) is a clinical ...
The Bellaire, Texas-based company said it had a loss of 1 cent per share. The company's shares closed at 59 cents. A year ago, they were trading at $2.75. _____ This story was generated by Automated Insights ...